
Bioorganic and Medicinal Chemistry Letters p. 4056 - 4060 (2017)
Update date:2022-08-05
Topics:
Wang, Cailan
Corte, James R.
Rossi, Karen A.
Bozarth, Jeffrey M.
Wu, Yiming
Sheriff, Steven
Myers, Joseph E.
Luettgen, Joseph M.
Seiffert, Dietmar A.
Wexler, Ruth R.
Quan, Mimi L.
A series of macrocyclic factor XIa (FXIa) inhibitors was designed based on an analysis of the crystal structures of the acyclic phenylimidazole compounds. Further optimization using structure-based design led to inhibitors with pM affinity for FXIa, excellent selectivity against a panel of relevant serine proteases, and good potency in the activated partial thromboplastin time (aPTT) clotting assay.
View MoreTianjin Boron PharmaTech Co.,Ltd.(expird)
Contact:86-022-59845187
Address:B9-401, Tianda Science Park,No.80,4th Avenue,TEDA,Tianjin, China
Jiangsu Institute of Ecomones Co., Ltd
website:http://www.jsmone.com
Contact:+86-519-82821700
Address:95 Huanyuan N. Road, Jintan, Jiangsu, China
HANGZHOU ZHONGCHANG SCIENTIFIC CO.,LTD
Contact:+86-571-88932183
Address:Hangzhou
Henan Yellow River New Material Technology Co.Ltd.
website:http://www.yellowriverchem.com
Contact:0086-373-7278760
Address:Chengguan Town, Yuanyang County
website:http://www.lidepharma.com
Contact:+86-25-58409506
Address:N0.2-309 2/F Chungking Express Nos.36 Nathan Road,Kowloon, HK
Doi:10.1039/c2cc30776f
(2012)Doi:10.1002/cmdc.201100334
(2011)Doi:10.1021/jo200685e
(2011)Doi:10.1016/S0040-4039(00)01939-0
(2001)Doi:10.1246/cl.2012.920
(2012)Doi:10.1016/S0040-4020(00)01131-5
(2001)